Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers

Summary

To evaluate the safety, tolerability, pharmacokinetics and immunogenicity of repeat administration (two doses) of intravenous (IV) ETI-204.

Timeline

Start

2013-07-23

Primary completion

2014-04-19

Completion

2014-04-19

Publications

• Nagy CF, Leach TS, Hoffman JH, Czech A, Carpenter SE, Guttendorf R. Pharmacokinetics and Tolerability of Obiltoxaximab: A Report of 5 Healthy Volunteer Studies. Clin Ther. 2016 Sep;38(9):2083-2097.e7. doi: 10.1016/j.clinthera.2016.07.170. Epub 2016 Aug 24.

Drugs

Indications